The panelists emphasized that selecting a therapy is only one step toward improving outcomes for patients with heart failure.
Publication|Articles|September 21, 2026
Pharmacy Practice in Focus: Health Systems
- September 2026
- Volume 15
- Issue 5
Comparison of Weight-Based vs Non–Weight-Based Norepinephrine Dosing in Patients With Septic Shock
Fact checked by: Ron Panarotti
Weight-based norepinephrine dosing did not improve time to goal MAP, and median dose was similar compared with non–weight-based dosing in patients with septic shock.
Advertisement
Advertisement
To determine time to first goal, mean arterial pressure (MAP), and median norepinephrine dose in patients with septic shock treated with weight-based dosing (WBD) compared with non–weight-based dosing (non-WBD).
Related to this article
Pharmacists describe their experiences using DEA certificates for controlled substance prescribing in different practice settings, as well as barriers and opportunities for future expansion.
A biologic stewardship framework can enhance consistency, safety, and sustainability of biologic use in health systems.
Pharmacists are well equipped to manage DOAC therapy by providing initial education, adherence support, and safety monitoring.
Pharmacists play a key role in guiding age- and risk-based vaccination decisions to protect against invasive and noninvasive disease.
Peer Reviewed
Gepotidacin and zoliflodacin show comparable efficacy to standard care for urogenital gonorrhea, offering promising alternatives given the recent rise in antimicrobial resistance.
Pharmacists can educate patients about staying up to date on immunizations and discuss fall prevention strategies.
Ataxia-telangiectasia (A-T) is a rare neurodegenerative disorder that primarily affects the nervous system, causing progressive loss of muscle control and coordination.
Advertisement
Advertisement